One of the key highlights is the “State of Molecular Diagnostics” panel at 2:30pm EST, featuring industry leaders including Virax Biolab’s COO, Dr Nigel McCracken, and moderated by North American Editor Jonathan D. Grinstein, PhD.
One of the key highlights is the “State of Molecular Diagnostics” panel at 2:30pm EST, featuring industry leaders including Virax Biolab’s COO, Dr Nigel McCracken, and moderated by North American Editor Jonathan D. Grinstein, PhD.